Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: Contraception

  • Beliefs About Women’s Virtue and Chastity May Play a Role in Latina Risk Behaviors

    The authors of a recent study revealed that endorsement of certain marianismo beliefs, related to women acting virtuous and chaste, may promote abstinence, but also are associated with sexual risk behaviors.

  • Research Confirms the Value of Title X for Improving Contraception Access

    Clients of Title X programs have greater access to a wide range of contraceptive methods, although reach has been limited by federal funding, state laws, and the Trump-era gag rule. A study revealed that people receiving contraception care from non-Title X clinics had lower proportions of receiving long-acting reversible contraception methods, nonoral hormonal methods, and extended supplies of oral contraceptives.

  • State Laws and Court Decisions Bring More Uncertainty to Reproductive Health

    In recent months, abortion-ban states have seen even more drastic bills and changes to their citizens’ reproductive health and lives. While abortion bans have closed clinics and prevented physicians from providing standard care to women experiencing pregnancy crises, the states have gone even further, now threatening contraceptives and fertility treatment.

  • New Research on Advance Provision Reveals Interest and Use in United States Since 2022

    Interest in advance provision of abortion medication was high even before the U.S. Supreme Court overturned Roe v. Wade, according to recent research. Many of those interested in advance provision were more likely to be highly motivated to prevent pregnancy. They had been using highly effective contraceptives, were well-educated, had private insurance, and were not poor.

  • As Uncertainty Looms, More People Request Advance Provision of Mifepristone

    Interest in advance provision of abortion medications mifepristone and misoprostol has increased dramatically in the post-Roe era. It remains popular as a U.S. Supreme Court case looms over whether mifepristone should remain available. Advance provision is one tool to help expand access to the medication.

  • Improve Screening and Retesting for Trichomoniasis

    Infection by the protozoan Trichomonas vaginalis is the most common nonviral sexually transmitted infection, with an estimated 6.8 million cases in the United States annually. It can go undiagnosed because most infected people (up to three out of four) do not experience symptoms. Left undiagnosed and untreated, trichomoniasis can increase the risk of pelvic inflammatory disease, infertility, and acquiring HIV and other STIs.

  • National Screening Guidelines for Chlamydia

    Reproductive and sexual health providers could reference evidence-based national guidelines for chlamydia screening and care, including guidelines from the U.S. Preventive Services Task Force, the Centers for Disease Control and Prevention, and the American Academy of Family Physicians.

  • Best Practices Needed in Screening and Treating Chlamydia

    Chlamydia infection affects more than 1.7 million people each year, making it the most common bacterial STI. Using a screening tool and checklist, a family planning clinic found success in improving the chlamydia screening rate, identifying more cases of the STI, and making patient visits more efficient by reducing time spent on visits.

  • New Study Shows Oral Contraceptives Decrease Risk of Hypothyroidism

    When researchers decided to explore the link between hormonal birth control and the risk of hypothyroidism, they made a surprising discovery: Contrary to earlier evidence, hormonal contraception decreases the risk of developing hypothyroidism.

  • Mental Health Screening Needed for Optimal Contraceptive Counseling

    Mental health conditions are common among people of reproductive age. Still, both physicians and patients may have misconceptions about using hormonal contraception if patients are diagnosed with depression or other mental health issues. New research suggests that barriers to effective contraceptive use should be addressed, and clinicians need to dispel myths about the negative psychiatric impacts of hormonal contraceptives.